Omcazio
Cabozantinib laurylsulfate · Handa Pharma
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Omcazio ingredients
| Active ingredient | Strength |
|---|---|
| Cabozantinib Laurylsulfate | 23 mg/1, 34.5 mg/1, 11.5 mg/1 |
What Omcazio is used for
Omcazio is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Omcazio
- Generic name
- Cabozantinib laurylsulfate
- Made by
- Handa Pharma
- Forms
- Capsule
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA220613
- On the US market since
- 2026
Official information
- MedlinePlus drug information (search for Cabozantinib laurylsulfate)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Omcazio?
Omcazio (Cabozantinib laurylsulfate) is a cancer medicine made by Handa Pharma, approved by the US FDA.
What are the ingredients of Omcazio?
Omcazio contains Cabozantinib Laurylsulfate (23 mg/1, 34.5 mg/1, 11.5 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA